Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Pharma News
>
2019
Pharma News, 2019
Roche pushes back Spark tender a third time. Will it close the deal on time — or ever?
Roche has said a delay in the U.
FDA finds testing issues at Torrent plant
A year after Torrent Pharmaceuticals first began recalling tainted losartan products manufactured at its Indrad plant, the FDA paid a visit.
California jury hits Bayer with $2 billion award in Roundup cancer trial
(Reuters) - A California jury on Monday awarded more than $2 billion to a couple who claimed Bayer AG’s glyphosate-based Roundup weed killer caused their cancer, in the largest U.
NHS to tackle elderly over-medication with 200 new pharmacists
The NHS has announced plans to recruit an ‘army’ of experts to tackle over-medication in care homes, with many already in place.
What you need to know about the U.S. measles outbreak
(Reuters) - The United States so far this year has recorded 839 cases of measles in 23 states, its largest outbreak since public health officials in 2000 declared the disease eradicated, the C...
3M’s $6.725 Billion Acquisition Of Acelity And Its KCI Subsidiaries
Simpson Thacher represented a consortium comprised of funds advised by Apax Partners (the “Apax Funds”), together with Canada Pension Plan Investment Board (“CPPIB”) and the Pu...
Novartis buys dry eye drug from Takeda for up to $5.3 billion
TOKYO/ZURICH (Reuters) - Novartis is buying dry-eye drug Xiidra from Takeda Pharmaceutical Co for up to $5.
Study shows new drug effective in overcoming ibrutinib resistance in mantle cell lymphona
The experimental treatment IACS-010759 strongly inhibited tumor growth in a mouse model of mantle cell lymphoma resistant to the standard chemotherapy ibrutinib (right column).
GW Pharma's epilepsy drug meets main goal in late-stage trial
(Reuters) - GW Pharmaceuticals Plc said on Monday its drug Epidiolex was successful in treating seizures in patients with a rare form of childhood epilepsy called tuberous sclerosis complex du...
AstraZeneca-Daiichi breast cancer treatment shows promise in latest study
(Reuters) - An experimental breast cancer drug being developed by British drugmaker AstraZeneca and Japan’s Daiichi Sankyo’s met its main goal in a mid-stage study, bolstering their positi...
FDA approves first treatment for children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
The U.
Biological barrier could keep cancer from metastasizing
Cancer might not be so difficult to kill if it didn't have the terrifying ability to spread throughout the body.
33
34
35
36
37
38
39
40
41
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds